Male, 22
DIAGNOSIS ANALYSIS GOAL NURSING RATIONALE EVALUATION
INTERVENTIONS
Ineffective airway Due to trauma that The patient will be – Assessed – Provides a basis The patient has obtain
clearance related to has occurred over the able to have effective respiratory rate. for evaluating effective airway
increased production of ribs, an intense airway clearance adequacy of clearance
bronchial secretions inflammatory after the intervention ventilation.
secondary to fluid shift to response occurred. within the hours of
extravascular Exudation of plasma, the shift. – Use of accessory
compartment. leukocytes, – Noted chest muscles of
infiltration of mast movement; use respiration may
Cues: cells, growth factors of accessory occur in response
-The patient has a and inflammatory muscles during to ineffective
tracheostomy leukocytes occurs in respiration. ventilation.
- the patient use to point effect. These fluid and
his throat exudates crosses the – Auscultated – Crackles indicate
permeable membrane breath sounds; accumulation of
of the pleurae causing noted areas with secretions and
it to accumulate in presence of inability to clear
this membranous adventitious airways.
space. Instead of the sounds.
lungs being able to
function normally, – Documented – Expectorations
these fluids inhibit the respiratory may be different
lungs to expand secretions: when secretions
anteroposteriorly thus character and are very thick.
causing ineffective amount of
breathing and sputum.
discomfort for the
patient. – Positioning helps
– Maintained maximize lung
patient on expansion.
moderate high
back rest.
– Checked for
obstructions:
accumulation of
– To maintain
adequate airway
patency.
– Duration should
be limited to
secretions. reduce hazard of
hypoxia, damage
– Suctioned airway mucosa
patient limited and impair cilia
to 5-sec action.
duration. – Increases lumen
size of the
tracheobronchial
tree, thus
decreasing
resistance to
airflow and
improving oxygen
delivery.
Pantoprazole 40g TIV OD Gastric acid pump Short-term Hypersensitivity to (>1%) GI: diarrhea, – Monitor for and
inhibitor; belongs treatment of pantoprazole or flatulence, immediately report
to a class of erosive esophagitis other PPIs; severe abdominal pain. S&S of
antisecretory associated with hepatic CNS: Headache, angioedema or
compounds. GERD. insufficiency, insomnia. Skin: severe skin
Gastric acid cirrhosis. rash. reaction.
secretion is – Lab tests: urea
decreased by CAUTIOUS USE breath test 4-6 wks
inhibiting the H+, Mild to moderate after completion of
K+-ATPase enzyme hepatic therapy.
system responsible insufficiency;
for acid production. pregnancy
(category B).
lactation. Safety
and effectiveness in
children <18 years
are not established.
Ceftriaxone 1g Bactericidal: Perioperative Contraindicated CNS: head – Perform skin test
Prophylaxis with allergy to ache,dizziness, before
IV Inhibits synthesis cephalosporin or lethargy,parestesia administering to
of Bacterial cell penicillins or detect if the patient
q12 wall, causing cell GI: nausea,
penicillins is allergic to the
death vomiting, drug
abdominal pain, – Assess for patient’s
flatulence, liver history of liver and
toxicity renal depression,
GU: nephrotoxicity lactation and
pregnancy
Hematologic: bone – Have vitamin K
marrow depression available in case
hperprothombinem
Hypersensitivity: ia occurs
ranging from rash,
fever to – Discontinue if
anaphylaxis hypersensitivity
occurs
Local: pain, Inform the
inflammation at IV patient about
site the side effects.
– Instruct patient to
avoid alcohol
while taking the
drug and for 3 days
because severe
reactions often
occur